The role of CD151 as a clinical prognostic marker in prostate cancer

被引：0
|
作者：
Newell, B.
Williams, E.
Opeskin, K.
Bolton, D.
Frauman, A.
机构：
[1] Univ Melbourne, Melbourne, Vic, Australia
[2] Monash Univ, Melbourne, Vic 3004, Australia
[3] St Vincents Hosp, Melbourne, Vic, Australia
来源：
BJU INTERNATIONAL | 2007年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：6 / 6
页数：1
相关论文
共 50 条
  • [1] CD151 as a prognostic indicator in malignancy of the bladder and prostate
    Williams, A.
    McPherson, V.
    Martinez, C.
    Vasquez, C.
    Chan, S.
    Gomez-Lemus, J.
    Rizkalla, K.
    Chalasani, V.
    Rajgopal, R.
    Zijlstra, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [2] Tetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancer
    Voss, M. A.
    Gordon, N.
    Maloney, S.
    Ganesan, R.
    Ludeman, L.
    McCarthy, K.
    Gornall, R.
    Schaller, G.
    Wei, W.
    Berditchevski, F.
    Sundar, S.
    BRITISH JOURNAL OF CANCER, 2011, 104 (10) : 1611 - 1618
  • [3] Tetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancer
    M A Voss
    N Gordon
    S Maloney
    R Ganesan
    L Ludeman
    K McCarthy
    R Gornall
    G Schaller
    W Wei
    F Berditchevski
    S Sundar
    British Journal of Cancer, 2011, 104 : 1611 - 1618
  • [4] CD151 and cell motility in prostate cancer
    Detchokul, Sujitra
    Parker, Michael W.
    Williams, Elizabeth D.
    Herdiman, Olivia M.
    Davis, Melissa
    Kee, Kelvin
    Bolton, Damien M.
    Frauman, Albert G.
    CANCER RESEARCH, 2012, 72
  • [5] CD151 and prostate cancer progression: A review of current literature
    Kang, Zhen
    Luo, Yanping
    Xiao, Enhua
    Li, Qiubai
    Wang, Liang
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2023, 19 (04) : 434 - 438
  • [6] CD151 expression in prostate cancer metastases: a potential target?
    Newell, B.
    Detchokul, S.
    Williams, E.
    Bolton, D.
    Frauman, A.
    BJU INTERNATIONAL, 2009, 103 : 38 - 38
  • [7] CD151 is associated with prostate cancer cell invasion and lymphangiogenesis in vivo
    Detchokul, Sujitra
    Newell, Bradley
    Williams, Elizabeth D.
    Frauman, Albert G.
    ONCOLOGY REPORTS, 2014, 31 (01) : 241 - 247
  • [8] Integrin-associated CD151 is a suppressor of prostate cancer progression
    Han, Rongbo
    Hensley, Patrick J.
    Li, Jieming
    Zhang, Yang
    Stark, Timothy W.
    Heller, Allie
    Qian, Hai
    Shi, Junfeng
    Liu, Zeyi
    Huang, Jian-An
    Jin, Tengchuan
    Wei, Xiaowei
    Zhou, Binhua P.
    Wu, Yadi
    Kyprianou, Natasha
    Chen, Jinfei
    Yang, Xiuwei H.
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2020, 12 (04): : 1428 - 1442
  • [9] CD151
    Ashman, LK
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2002, 16 (03): : 223 - 226
  • [10] Clinical significance of CD151 expression in patients with advanced gastric cancer
    Kang, B.
    Kim, J.
    Lee, S.
    Chae, Y.
    Lee, Y.
    Lee, D.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S637 - S638
12345